![Marlies Janßen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Marlies Janßen is currently the Co-Managing Director at Fortuna Herstellung GmbH.
She also holds positions as a Member-Supervisory Board at NSI NV and Erasmus Q-Intelligence BV.
Previously, Ms. Janßen served as the Managing Director at cas central compounding Baden-Württemberg GmbH.
Aktiva positioner av Marlies Janßen
| Företag | Position | Start |
|---|---|---|
| NSI N.V. | Direktör/Styrelseledamot | 2024-02-28 |
Fortuna Herstellung GmbH
 Fortuna Herstellung GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Verkställande Direktör | - |
Erasmus Q-Intelligence BV | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Marlies Janßen
| Företag | Position | Slut |
|---|---|---|
cas central compounding Baden-Württemberg GmbH
 cas central compounding Baden-Württemberg GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical preparation services | Verkställande Direktör | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
11
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
NSI NV
 NSI NV Real Estate Investment TrustsFinance Operates as a commercial real estate investment company with a focus on office buildings | Finance |
Fortuna Herstellung GmbH
Fortuna Herstellung GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
cas central compounding Baden-Württemberg GmbH
cas central compounding Baden-Württemberg GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical preparation services | Health Technology |
Erasmus Q-Intelligence BV |
